Literature DB >> 28013053

Surviving Naegleria fowleri infections: A successful case report and novel therapeutic approach.

Travis W Heggie1, Thomas Küpper2.   

Abstract

Naegleria fowleri is a deadly human pathogen recognized as the causative agent of Primary Amoebic Meningitis (PAM). N. fowleri is commonly found in warm freshwater environments such as natural or man-made lakes, hot springs, and resort spas frequented by tourists. PAM infections have a mortality rate between 95 and 99% with minimal progress being made toward a successful treatment therapy. We report the case of a 12-year old American female who survived a PAM infection and propose a new drug therapy which includes the antimicrobial drug Miltefosine.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Miltefosine; Naegleria fowleri; Primary Amoebic Meningitis

Mesh:

Substances:

Year:  2016        PMID: 28013053     DOI: 10.1016/j.tmaid.2016.12.005

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  8 in total

1.  Naegleria fowleri infections.

Authors:  W Matthew Linam; Jennifer R Cope
Journal:  Travel Med Infect Dis       Date:  2017-05-10       Impact factor: 6.211

2.  Real-Time PCR Confirmation of a Fatal Case of Primary Amoebic Meningoencephalitis in Turkey Caused by Naegleria fowleri or Brain-Eating Amoeba.

Authors:  Koray Oncel; Leman Karaagac; Hande Dagcı; Mehmet Aykur
Journal:  Acta Parasitol       Date:  2022-01-12       Impact factor: 1.440

3.  Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole.

Authors:  Dalila Y Martínez; Fanny Bravo-Cossio; María Del Carmen Valdivia-Tapia; Nilton Yhuri Carreazo; Alfonso M Cabello-Vilchez
Journal:  Acta Parasitol       Date:  2022-07-21       Impact factor: 1.534

4.  A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing.

Authors:  Qiang Wang; Jianming Li; Jingkai Ji; Liuqing Yang; Li Chen; Rongrong Zhou; Yang Yang; Haixia Zheng; Jing Yuan; Liqiang Li; Yuhai Bi; George F Gao; Jinmin Ma; Yingxia Liu
Journal:  BMC Infect Dis       Date:  2018-07-28       Impact factor: 3.090

5.  Case Report and Literature Review: Bacterial Meningoencephalitis or Not? Naegleria fowleri Related Primary Amoebic Meningoencephalitis in China.

Authors:  Wenjuan Zhou; Yuzhen Ouyang; Di Zhang; Sheng Liao; Hui Liang; Lingling Zhao; Chunyuan Chen
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

Review 6.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

7.  Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases.

Authors:  Iñigo Arberas-Jiménez; Sara García-Davis; Aitor Rizo-Liendo; Ines Sifaoui; María Reyes-Batlle; Olfa Chiboub; Rubén L Rodríguez-Expósito; Ana R Díaz-Marrero; José E Piñero; José J Fernández; Jacob Lorenzo-Morales
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

Review 8.  Primary Amoebic Meningoencephalitis by Naegleria fowleri: Pathogenesis and Treatments.

Authors:  Andrea Güémez; Elisa García
Journal:  Biomolecules       Date:  2021-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.